Thousand Oaks, CA, United States of America

Xiaofen Li

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Amgen Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaofen Li. Retrieved from https://idiyas.com/inventor/xiaofen-li-d6u2unm7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xiaofen Li - Innovator in Pharmaceutical Chemistry

Introduction

Xiaofen Li is a prominent inventor based in Thousand Oaks, CA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for therapeutic uses. Her work is characterized by a commitment to advancing medical science through her inventions.

Latest Patents

Xiaofen Li holds a patent for SMARCA2-VHL degraders. The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention, and therapeutic uses thereof. This patent highlights her expertise in creating novel solutions for complex medical challenges.

Career Highlights

Xiaofen Li is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to drug development. Her role at Amgen allows her to collaborate with other experts in the field and contribute to groundbreaking research and development projects.

Collaborations

One of her notable coworkers is Victor J. Cee, with whom she collaborates on various projects. Their partnership exemplifies the importance of teamwork in the pursuit of scientific advancements.

Conclusion

Xiaofen Li's contributions to pharmaceutical chemistry and her innovative patent for SMARCA2-VHL degraders underscore her role as a key figure in the field. Her work continues to inspire advancements in medical science and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…